4th Inflammasome Therapeutics Summit
Evvnt Promotion / evvnt
Archivo
29.11.2022 - 01.12.2022 Boston Park Plaza, 50 Park Plaza, 02116 Boston, USA
Time: 09:00 to 16:30
Temas de la conferencia
The 4th Inflammasome Therapeutics Summit is the only industry-led forum uniting large pharma, biotechs, and academic KOLs, with the common goal of accelerating the practical translation and clinical development of inflammasome-targeted drugs, which are shaking up the immunology R and D landscape.
The 4th Inflammasome Therapeutics Summit is the only industry-led forum uniting large pharma, biotechs, and academic KOLs, with the common goal of accelerating the practical translation and clinical development of inflammasome-targeted drugs, which are shaking up the immunology R and D landscape.
Organizador profesional (PCO)
Hanson Wade
Hanson Wade
Observaciones
Brochure: https://go.evvnt.com/1252816-3?pid=4832
Speakers: Alan Watt, Chief Scientific Officer, NodThera, Bruno Reversade, Professor and Director, Laboratory of Human Genetics and Therapeutics GIS and IMCB, A*STAR, and more.
Brochure: https://go.evvnt.com/1252816-3?pid=4832
Speakers: Alan Watt, Chief Scientific Officer, NodThera, Bruno Reversade, Professor and Director, Laboratory of Human Genetics and Therapeutics GIS and IMCB, A*STAR, and more.
Información e inscripción:
https://go.evvnt.com/1252816-2?pid=4832
Ms. Jessica Durston
Medicina General
Idioma
Inglés
Inglés
Cuota del Congreso
USD 2199.00 - USD 5696.00
USD 2199.00 - USD 5696.00
Los participantes esperaban
1000 - 1000
1000 - 1000
Cantacto organizador
83 Great Titchfield Street
W1W 6RH London
United Kingdom
83 Great Titchfield Street
W1W 6RH London
United Kingdom
"Going International fomenta el acceso a la educación y a la formación continua independientemente de fronteras sociales, geográficas y nacionales."
